Effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment for multiple-day anthracycline-induced nausea and vomiting.

Quanfu Li,Yungaowa Wu,Wenjuan Wang,Shuqin Deng,Caihong Jiang,Feng Chen,Jun Zhao,Hui Li,Xiaojun Bai,Jixiang Hou,Lenggaowa Da,Lanzhen Zhao,Jiali Gao,Gaowa Jin

Current Problems in Cancer（2019）

引用 7|浏览8

暂无评分

摘要

Combined aprepitant therapy is efficient and safe in the multiple-day anthracycline chemotherapy-induced nausea and vomiting control and is recommended for the clinical use.

查看译文

关键词

Aprepitant,CINV,Multiple-day chemotherapy,Anthracycline

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要